Paper1979245
Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro.
Shalinsky DR and 2 others. Cancer Res, 1990. Cited by 59 papers, by iCite.
Cite this record
ConductScience Library. Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro. Papers, record 1979245. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1979245
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Squamous Cell | Major topic |
| Dipyridamole | Major topic |
| Drug Resistance | Major topic |
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | |
| Cell Survival | |
| Colchicine | |
| Drug Synergism | |
| Etoposide | |
| Humans | |
| In Vitro Techniques | |
| Membrane Glycoproteins | |
| Neoplasm Proteins | |
| Verapamil | |
| Vinblastine |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA 09290-11 | NCI NIH HHS | United States | PubMed | PubMed | |
| CA 23100 | NCI NIH HHS | United States | P30CA023100 | PubMed and NIH | NIH RePORTER |
| CA 35309 | NCI NIH HHS | United States | R01CA035309 | PubMed and NIH | NIH RePORTER |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36273882 | Effect of Dipyridamole on Membrane Energization and Energy Transfer in Chromatophores of Rba. sphaeroides. | Biochemistry (Mosc) | 2022 | https://conductscience.org/library/papers/36273882 | PubMed |
| 28510131 | Generation of radical form of dipyridamole at illumination of photosynthetic reaction centers of Rb. sphaeroides. | Dokl Biochem Biophys | 2017 | https://conductscience.org/library/papers/28510131 | PubMed |
| 10696508 | Brain microvascular P-glycoprotein and a revised model of multidrug resistance in brain. | Cell Mol Neurobiol | 2000 | https://conductscience.org/library/papers/10696508 | PubMed |
| 8611395 | Dipyridamole increases VP16 growth inhibition, accumulation and retention in parental and multidrug-resistant CHO cells. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8611395 | PubMed |
| 8609155 | Modulation of multidrug resistance by BIBW22BS in blasts of de novo or relapsed or persistent acute myeloid leukemia ex vivo. | J Cancer Res Clin Oncol | 1996 | https://conductscience.org/library/papers/8609155 | PubMed |
| 8431967 | Modulation of drug cytotoxicity in wild-type and multidrug-resistant tumor cells by stereoisomeric series of C-20'-vinblastine congeners that lack antimicrotubule activity. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8431967 | PubMed |
| 8094975 | Selective modulation of vinblastine sensitivity by 1,9-dideoxyforskolin and related diterpenes in multidrug resistant tumour cells. | Br J Cancer | 1993 | https://conductscience.org/library/papers/8094975 | PubMed |
| 8094005 | Regulation of initial vinblastine influx by P-glycoprotein. | Br J Cancer | 1993 | https://conductscience.org/library/papers/8094005 | PubMed |
| 7767952 | Antibiotic C3368-A, a fungus-derived nucleoside transport inhibitor, potentiates the activity of antitumor drugs. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7767952 | PubMed |
| 7765325 | Pharmacologic circumvention of multidrug resistance. | Cytotechnology | 1993 | https://conductscience.org/library/papers/7765325 | PubMed |
| 7533669 | Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7533669 | PubMed |
| 1680368 | Modulation of vinblastine sensitivity by dipyridamole in multidrug resistant fibrosarcoma cells lacking mdr1 expression. | Br J Cancer | 1991 | https://conductscience.org/library/papers/1680368 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| CMAS | 55907 | PubTator's text mining | https://conductscience.org/library/genes/55907 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1979245
GET https://conductscience.org/api/papers/v1/1979245/authors